Literature DB >> 10433011

Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines.

A Takeuchi1, S Kaneko, E Matsushita, T Urabe, A Shimoda, K Kobayashi.   

Abstract

We investigated the expression of the drug resistance-related genes, multidrug resistance gene 1 (MDR1), multidrug resistance associated protein gene (MRP), and the DNA topoisomerase IIalpha, DNA topoisomerase IIbeta, and glutathione-S-transferase pi gene (GST-pi) in three human hepatoma cell lines (HepG 2, HuH 7, SK-Hep-1) with or without drug treatment with interferon-alpha (IFN-alpha) and cisplatin (CDDP), by a reverse transcription-polymerase chain reaction (RT-PCR) method and a competitive PCR method. The signals of the MDR1, MRP, topoisomerase IIalpha, and topoisomerase IIbeta genes in HepG2 were weakened when IFN-alpha was added to CDDP. In SK-Hep-1, the administration of CDDP alone increased the signals of MDR1 while the addition of IFN-alpha decreased the signals, and the signals of GST-pi were decreased by IFN-alpha plus CDDP. In summary, our results concerning the expression of drug resistance-related genes in three human hepatoma cell lines demonstrate that IFN-alpha may modulate the mechanism of resistance to CDDP in liver cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433011     DOI: 10.1007/s005350050273

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

1.  Modification of the P-glycoprotein dependent pharmacokinetics of digoxin in rats by human recombinant interferon-alpha.

Authors:  Makrem Ben Reguiga; Laurence Bonhomme-Faivre; Simone Orbach-Arbouys; Robert Farinotti
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

2.  Effect of co-administration of tacrolimus on the pharmacokinetics of multiple subcutaneous administered interferon-alpha in rats.

Authors:  Hiroyuki Yamazaki; Masateru Miyake; Toru Nishibayashi; Tadashi Mukai; Masaaki Odomi; Tatsuhiro Ishida; Hiroshi Kiwada
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 3.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Heterogeneity of anticancer drug sensitivity in squamous cell carcinoma of the tongue.

Authors:  Minako Suzuki; Hiroshi Ishikawa; Akira Tanaka; Izumi Mataga
Journal:  Hum Cell       Date:  2010-12-29       Impact factor: 4.174

5.  Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells.

Authors:  Xianlong Ling; Yuan Zhou; Shi-Wei Li; Bin Yan; Lei Wen
Journal:  Int J Biol Sci       Date:  2010-12-06       Impact factor: 6.580

6.  Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.

Authors:  Lili Yang; Chunjuan Du; Lei Wu; Jinpu Yu; Xiumei An; Wenwen Yu; Shui Cao; Hui Li; Xiubao Ren
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.